Early Endovascular Treatment in Isolated Internal Carotid Artery Occlusion
NCT07016854 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2025-06-12
Summary
The primary hypothesis being tested in this trial is that acute ischemic stroke with isolated internal carotid artery occlusion will have improved clinical outcomes when given early endovascular treatment compared with that of given best medical treatment.
Conditions
- Stroke, Acute Ischemic
Interventions
- PROCEDURE
-
Endovascular treatment
Endovascular treatment could be performed with any recanalization strategy, such as thrombectomy with aspiration or stent and angioplasty with balloon dilation or stent implantation, depending on the operator's choice and anatomical and radiological circumstances. In the setting of emergency stenting, the use of antiplatelet agents will depend on operator preference, anatomy, and bleeding risk.
- DRUG
-
The best medical treatment
Medical treatment includes intravenous thrombolysis, anticoagulant or antiplatelet drugs, etc. which is determined by the attending physician according to the Chinese guidelines or expert consensus.
Sponsors & Collaborators
-
Sir Run Run Shaw Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-30
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- China
Study Locations
More Related Trials
-
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
NCT07139301 ·Status: RECRUITING ·Phase: NA
-
Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window
NCT05634382 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT05686642 ·Status: RECRUITING ·Phase: PHASE2
-
Phase III Clinical Trial of Y-2 Sublingual Tablets in the Treatment of Acute Ischemic Stroke
NCT04950920 ·Status: COMPLETED ·Phase: PHASE3
-
Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China(IVTIS)
NCT06131385 ·Status: RECRUITING
-
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
NCT07139314 ·Status: RECRUITING ·Phase: NA
-
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
NCT06755944 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Carotid Endarterectomy Versus Stenting in Patients With Acute Stage of Ischemic Stroke.
NCT07083986 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
NCT07030621 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed;
NCT04290494 ·Status: COMPLETED
-
Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF
NCT06057467 ·Status: RECRUITING ·Phase: NA
-
Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke
NCT03552354 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of NBP on the Collateral Circulation in ICA/M1 Occlusion
NCT02594995 ·Status: COMPLETED ·Phase: PHASE4
-
Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset
NCT02854592 ·Status: COMPLETED
-
Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial
NCT06429384 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion
NCT06211712 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT
NCT05198323 ·Status: RECRUITING ·Phase: PHASE2
-
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
NCT07333950 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Y-3 for Injection in the Treatment of Acute Ischemic Stroke
NCT06517173 ·Status: RECRUITING ·Phase: PHASE3
-
Revive AIS Patients ImmeDiately
NCT03007082 ·Status: UNKNOWN
-
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
NCT06115070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusion Therapy
NCT07323368 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
NCT04091945 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion
NCT07141303 ·Status: RECRUITING ·Phase: PHASE3
-
Acute Basilar Artery Occlusion: Endovascular Interventions vs Standard Medical Treatment
NCT02441556 ·Status: COMPLETED ·Phase: NA